中国北方多中心随机对照试验:局部进展期胃癌腹腔镜与开腹远端胃切除术的远期结局
该多中心非劣效性随机对照试验纳入中国北方五家三级医院的446例进展期胃癌患者,1:1随机分配至腹腔镜远端胃切除术(LDG)组或开腹远端胃切除术(ODG)组。主要终点为术后30天并发症与死亡率,次要终点为3年无病生存(DFS)率。结果显示LDG组3年DFS率为85.9%,ODG组为84.72%,两组无显著统计学差异(HR 1.12;95%CI 0.68-1.84,P=0.65)。
要点
- LDG与ODG在进展期胃癌患者中3年DFS率无显著差异。
- BMI<25 kg/m2、病理T4期及病理N2-3期是DFS的独立危险因素。
- LDG联合D2淋巴结清扫可获得与ODG相似的肿瘤学远期结局。
核心结论
- 与开腹远端胃切除术相比,腹腔镜远端胃切除术联合D2淋巴结清扫在进展期胃癌患者中3年无病生存率相似。
研究设计与样本
- 多中心、非劣效性、开放标签、平行随机对照试验,在中国北方五家三级医院开展。
- 2014年3月至2017年8月共随机分配446例进展期胃癌患者,1:1分配至LDG组(n=223)或ODG组(n=223)。
- 筛选后实际接受开腹手术214例,接受腹腔镜手术216例。
- 主要终点为术后30天并发症与死亡率,次要终点为3年DFS率。
- 试验注册于ClinicalTrials.gov(标识号NCT02464215)。
主要发现
- LDG组3年DFS率为85.9%,ODG组为84.72%,两组无显著统计学差异(HR 1.12;95%CI 0.68-1.84,P=0.65)。
- Cox回归确认BMI<25 kg/m2、病理T4期及病理N2-3期是DFS的独立危险因素。
临床怎么用
- 对于进展期胃癌需行远端胃切除术的患者,LDG联合D2淋巴结清扫可作为与ODG等效的术式选择。
- 术前评估应关注BMI、病理T分期及N分期,以识别DFS高危患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Laparoscopic distal gastrectomy (LDG) has become a common procedure for treating advanced gastric cancer (AGC) in China. However, there is uncertainty regarding its oncological outcomes compared to open distal gastrectomy (ODG). This study aims to compare the 3-year disease-free survival (DFS) rates among patients who underwent surgery for AGC in northern China. METHODS: A multicenter, non-inferiority, open-label, parallel, randomized clinical trial was conducted to evaluate patients with AGC who were eligible for distal gastrectomy at five tertiary hospitals in North China. In this trial, patients were randomly assigned preoperatively to receive either LDG or ODG in a 1:1 allocation ratio. The primary endpoint was postoperative morbidity and mortality within 30 days and the secondary endpoint was the 3-year DFS rate. This trial has been registered at ClinicalTrials.gov (Identifier: NCT02464215). RESULTS: A total of 446 patients were randomly allocated to LDG (n = 223) or ODG group (n = 223) between March 2014 and August 2017. After screening, a total of 214 patients underwent the open surgical approach, while 216 patients underwent laparoscopic surgery. The 3-year DFS rate was 85.9% for the LDG group and 84.72% for the ODG group, with no significant statistical difference (Hazard ratio 1.12; 95% CI 0.68-1.84, P = 0.65). Body mass index (BMI) < 25 kg/m2, advanced pathologic T4, and pathologic N2-3 category were confirmed as independent risk factors for DFS in the Cox regression. CONCLUSIONS: In comparison to ODG, LDG with D2 lymphadenectomy yielded similar outcomes in terms of 3-year DFS rates among patients diagnosed with AGC.
引用
- Xing J, Cai J, Wang X, et al. Long-term outcomes of laparoscopic versus open distal gastrectomy for patients with advanced gastric cancer in North China: a multicenter randomized controlled trial. Surg Endosc. 2024. PMID: 38981881. doi:10.1007/s00464-024-10952-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。